Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 276 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Blood Specimen Collection Clear all

Conditions: Lyme Disease, Healthy
Interventions: Lyme diagnostic assay; Diagnostic Test
Lead sponsor: DiaSorin Inc.; Industry
Eligibility: Not listed
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Stillwater, Minnesota

Conditions: Bone Marrow Transplantation, Hematopoietic Stem Cells, Multiple Myeloma, Lymphoma
Interventions: Neupogen, Hyperbaric oxygen therapy, Plerixafor; Drug · Procedure
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cancer, Healthy, Gastrointestinal Complication, Autoimmune Diseases, Infectious Disease, Women's Health: High-Risk Pregnancy, Dermatologic Disease, Blood Disease
Interventions: Observational; Other
Lead sponsor: iSpecimen Inc; Industry
Eligibility: 1 Year to 99 Years
Enrollment: 100,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2025
U.S. locations: 7
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 4 more

Conditions: Cancer
Interventions: Not listed
Lead sponsor: Global BioClinical; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Candidemia
Interventions: Not listed
Lead sponsor: T2 Biosystems; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 8
States / cities: Birmingham, Alabama • Augusta, Georgia • Detroit, Michigan + 3 more

Conditions: Alveolar Soft Part Sarcoma, Sarcoma
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 4 Years and older
Enrollment: 99,999 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Critically Ill Surgical Patients
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Melanoma, Myelodysplastic Syndrome, Multiple Myeloma, Lymphoma
Interventions: Tissue Registry Study; Other
Lead sponsor: SCRI Development Innovations, LLC; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Pulmonary Diseases
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 3,087 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Inflammation, Normal Controls, Metabolic Disease
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2031
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Blood Pressure
Interventions: Collecting blood pressure measurements with noninvasive blood pressure device; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Type 2 Diabetes
Interventions: Capillary HbA1c collection; Procedure
Lead sponsor: GRADE Study Group; Other
Eligibility: 30 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 5
States / cities: Phoenix, Arizona • Denver, Colorado • Honolulu, Hawaii + 2 more

Conditions: HIV
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1988 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sickle Cell Disease
Interventions: Plerixafor; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetes, Anemia
Interventions: TAP20-C, SAFE-T-FILL CAPILLARY BLOOD COLLECTION SYSTEM; Device
Lead sponsor: Seventh Sense Biosystems; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Cancer
Interventions: Blood Draw; Procedure
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 75 Years
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Healthy Volunteer
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 520 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2035
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Plasma Cell Myeloma, Multiple Myeloma
Interventions: Filgrastim, Plerixafor, Apheresis; Drug · Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cord Blood Stem Cell Transplantation, Cord Blood Transplantation, Hematopoietic Stem Cell Transplantation
Interventions: Not listed
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 250,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2099
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Ebola Virus Disease, Marburg Virus Disease
Interventions: cAd3-Marburg, cAd3-EBO-S; Biological
Lead sponsor: Albert B. Sabin Vaccine Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Leukemia, Lymphoma
Interventions: biologic sample preservation procedure; Other
Lead sponsor: Eastern Cooperative Oncology Group; Network
Eligibility: 0 Years to 120 Years
Enrollment: 1,873 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 214
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Aurora, Colorado + 156 more

Conditions: Myelodysplastic Syndromes(MDS)
Interventions: Not listed
Lead sponsor: PersImmune, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Irvine, California • La Jolla, California

Conditions: HPV Infection, HPV 16 Infection, High Risk HPV, Cervical Cancer Screening, Cervical Cancer Cin Grade, Cervical Cancer (Early Detection), HPV, HPV (Human Papillomavirus)-Associated, HPV DNA, HPV Infections, Screening Test
Interventions: Q-Pad hrHPV Test System; Device
Lead sponsor: Qurasense; Industry
Eligibility: 25 Years and older · Female only
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: New Haven, Connecticut • Minneapolis, Minnesota • Akron, Ohio

Conditions: Graft vs Host Disease, Healthy Volunteer, Graft-Versus-Host Disease
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Lyme Disease Diagnostic Assay - Collection of Whole Blood

Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers

Collection and Distribution of Biospecimens for Novel Research

Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples

Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)

Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research

Blood Sampling Pre- and Post-Propofol Administration to Characterize the Blood Proteome Using Different Research Assays

SCRI Tissue Testing Registry

Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases

Natural History of the Human Biological Response to Environmental Exposure and Injury

Data Collection for Validation of an NIBP Algorithm in Pregnant Women

The GRADE Capillary Blood Collection Pilot Study

Collection of Blood for Multiple Collaborative Studies

Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients

A Study to Compare Analytes in Blood Collected Using an Investigational Collection Device With a Commercial Predicate

Immune Reconstitution in Stem Cell Transplant Recipients

Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy

Collection of Transplant Stem Cells for Plasma Cell Myeloma

The Collection and Storage of Umbilical Cord Blood for Transplantation

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

Collection of Samples From Patients With MDS

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

Collection of Saliva and/ or Peripheral Blood From Healthy Volunteers for Research